UBS Group’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $593K | Sell |
|
|||||
|
2021
Q1 | $411K | Buy |
|
|||||
|
2020
Q4 | $325K | Sell |
|
|||||
|
2020
Q3 | $361K | Sell |
|
|||||
|
2020
Q2 | $579K | Buy |
|
|||||
|
2020
Q1 | $487K | Sell |
|
|||||
|
2019
Q4 | $1.22M | Buy |
|
|||||
|
2019
Q3 | $827K | Buy |
|
|||||
|
2019
Q2 | $674K | Buy |
|
|||||
|
2019
Q1 | $653K | Sell |
|
|||||
|
2018
Q4 | $875K | Buy |
|
|||||
|
2018
Q3 | $867K | Buy |
|
|||||
|
2018
Q2 | $582K | Buy |
|
|||||
|
2018
Q1 | $398K | Sell |
|
|||||
|
2017
Q4 | $447K | Sell |
|
|||||
|
2017
Q3 | $372K | Sell |
|
|||||
|
2017
Q2 | $572K | Buy |
|
|||||
|
2017
Q1 | $460K | Buy |
|
|||||
|
2016
Q4 | $110K | Sell |
|
|||||
|
2016
Q3 | $152K | Buy |
|
|||||
|
2016
Q2 | $100K | Buy |
|
|||||
|
2016
Q1 | $81K | Buy |
|
|||||
|
2015
Q4 | $66K | Buy |
|
|||||
|
2015
Q3 | $76K | Buy |
|
|||||
|
2015
Q2 | $44K | Buy |
|
|||||
|
2015
Q1 | $31K | Sell |
|
|||||
|
2014
Q4 | $50K | Buy |
|